# Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy

> **NCT05586724** · PHASE3 · RECRUITING · sponsor: **Angelica Lindén Hirschberg** · enrollment: 520 (estimated)

## Conditions studied

- Menopausal Symptoms

## Interventions

- **DRUG:** Micronized progesterone in continuous combination with oral estrogen
- **DRUG:** Norethisterone acetate in continuous combination with oral estrogen

## Key facts

- **NCT ID:** NCT05586724
- **Lead sponsor:** Angelica Lindén Hirschberg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-15
- **Primary completion:** 2026-09
- **Final completion:** 2027-12
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586724, "Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05586724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*